Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

This bill (S 1102) requires all health insurance plans in New Jersey - covering hospital services, medical expenses, individual policies, group plans, and health maintenance organizations - to cover the cost of continuous glucose monitoring systems when prescribed by a healthcare provider for treating glycogen storage disease. It applies to all new or renewed insurance contracts on or after the bill's effective date, mandating coverage "to the same extent as for any other medical condition." The law directly affects patients with glycogen storage disease who rely on these monitoring systems and insurers who must now include this coverage without additional cost-sharing. It does not change existing coverage standards for other conditions but ensures consistent access to this specific treatment tool.